Journal of the American College of Surgeons
Volume 196, Issue 1 , Pages 141-151 , January 2003

Clinical research for surgeons in palliative care: challenges and opportunities

  • Alexandra M Easson, MD, FRCSC, FACS

      Affiliations

    • Division of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada (Easson)
    • Corresponding Author InformationCorrespondence address: Alexandra M Easson, MD, FRCSC, Division of Surgical Oncology, Room 3-130, Princess Margaret Hospital, University Health Network, 610 University Ave, Toronto, Ontario M56 2M9, Canada.
  • ,
  • K.Francis Lee, MD

      Affiliations

    • Departments of Surgery, Baystate Medical Center, Tufts University School of Medicine, Springfield, MA (Lee), USA
  • ,
  • Karen Brasel, MD, FACS

      Affiliations

    • Medical College of Wisconsin, Milwaukee, WI, USA (Brasel)
  • ,
  • Robert S Krouse, MD

      Affiliations

    • Southern Arizona Veteran’s Affairs Health Care System, and the University of Arizona, Tucson, AZ (Krouse), USA

Received 17 October 2002 ,Accepted 17 October 2002.

References 

  1. Friel JP. Dorland’s illustrated medical dictionary. 26th ed. Philadelphia: WB Saunders; 1985;
  2. Lye M. Chronic cardiac failure in the elderly. In:  Tallis R,  Fillit H,  Brocklehurst J editor. Brocklehurst’s textbook of geriatric medicine and gerontology. Edinburgh: Churchill Livingstone; 1998;p. 288–312
  3. Deaths: Leading causes for 1999, National Vital Statistics Report. Accessed on 9/25/02 from: www.cdc.gov/nchs/data/nvsr/nvsr49/nvsr49_11.pdf. 2001
  4. Lynn J. Learning to care for people with chronic illness facing the end of life. JAMA. 2000;284:2508–2511
  5. Covinsky KE, Fuller JD, Yaffe K, et al.  Communication and decision-making in seriously ill patients (findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). J Am Geriatr Soc. 2000;48(5 Suppl):S187–S193
  6. Mandelblatt JS, Hadley J, Kerner JF, et al.  Patterns of breast carcinoma treatment in older women (patient preference and clinical and physical influences). Cancer. 2000;89:561–573
  7. Hayman JA, Fairclough DL, Harris JR, Weeks JC. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol. 1997;15:1252–1260
  8. Mazur DJ, Merz JF. How the manner of presentation of data influences older patients in determining their treatment preferences. J Am Geriatr Soc. 1993;41:223–228
  9. Terry PB, Vettese M, Song J, et al.  End-of-life decision making (when patients and surrogates disagree). J Clin Ethics. 1999;10:286–293
  10. Levine RS. Avoiding conflicts of interest in surrogate decision making (why ethics committees should assign surrogacy to a separate committee). J Clin Ethics. 1998;9:273–290
  11. Rogers J, Ridley S, Chrispin P, et al.  Reliability of the next of kins’ estimates of critically ill patients’ quality of life. Anaesthesia. 1997;52:1137–1143
  12. Haidet P, Hamel MB, Davis RB, et al.  Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med. 1998;105:222–229
  13. Jacobs TJ. On misreading and misleading patients. Some reflections on communications, miscommunications and countertransference enactments. Int J Psychoanal. 2001;82:653–669
  14. Shiminski-Maher T. Physician-patient-parent communication problems. Pediatr Neurosurg. 1993;19:104–108
  15. Weeks JC, Cook EF, O’Day SJ. Relationship between cancer patients prediction of prognosis and their treatment preferences. JAMA. 1998;279:1709–1714
  16. Ptacek JT, Eberhardt TL. Breaking bad news. A review of the literature. JAMA. 1996;276:496–502
  17. Vigano A, Bruera E, Jhangri GS, et al.  Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160:861–868
  18. Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients (prospective cohort study). Br Med J. 2000;320:469–472
  19. Sloan JA, Loprinzi CL, Laurine JA, et al.  A simple stratification factor prognostic for survival in advanced cancer (the good/bad/uncertain index). J Clin Oncol. 2001;19:3539–3546
  20. Morita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index (a scoring system for survival prediction of terminally ill cancer patients). Support Care Cancer. 1999;7:128–133
  21. Maltoni M, Nanni O, Pirovano M, et al.  Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage. 1999;17:240–247
  22. Knaus WA, Harrell FE, Lynn J, et al.  The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Ann Intern Med. 1995;122:191–203
  23. Vigano A, Dorgan M, Buckingham J, et al.  Survival prediction in terminal cancer patients (a systematic review of the medical literature). Palliat Med. 2000;14:363–374
  24. Fox E, Landrum-McNiff K, Zhong Z, et al.  Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. JAMA. 1999;282:1638–1645
  25. Seidman AD, Portenoy R, Yao TJ, et al.  Quality of life in phase II trials (a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor). J Natl Cancer Inst. 1995;87:1316–1322
  26. Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage. 1995;10:423–431
  27. Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?. Br J Cancer. 1990;62:695–699
  28. Child CG, Turcotte JC. Surgery and portal hypertension. In:  Child CGI editors. Major problems in clinical surgery: the liver and portal hypertension. Philadelphia: WB Saunders; 1964;p. 1–85
  29. Turcotte JG, Raper SE, Eckhauser FE. Portal hypertension. In:  Greenfield LJ,  Mulholland MW,  Oldham KT,  Zenelock GB editor. Philadelphia: JB Lippincott Co; 1996;p. 887–908
  30. Miner TJ, Jaques DP, Tavaf-Motamen H, Shriver CD. Decision making on surgical palliation based on patient outcome data. Am J Surg. 1999;177:150–154
  31. Michael M, Tannock IF. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ. 1998;158:1727–1734
  32. Osoba D. Rationale for the timing of health-related quality-of-life (HQL) assessments in oncological palliative therapy. Cancer Treat Rev. 1996;22(Suppl A):69–73
  33. Seely JF, Mount BM. Palliative medicine and modern technology. Can Med Assoc J. 1999;161:1120–1121
  34. McLeod RS. Quality-of-life measurement in the assessment of surgical outcome. Adv Surg. 1999;33:293–309
  35. Shekarriz B, Shekarriz H, Upadhyay J, et al.  Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer. 1999;85:998–1003
  36. Prat F, Chapat O, Ducot B, et al.  Predictive factors for survival of patients with inoperable malignant distal biliary strictures (a practical management guideline). Gut. 1998;42:76–80
  37. Bolder U, Brune A, Schmidt S, et al.  Preoperative assessment of mortality risk in hepatic resection by clinical variables (a multivariate analysis). Liver Transpl Surg. 1999;5:227–237
  38. Feuer DJ, Broadley KE, Shepherd JH, Barton DP. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;4:CD002764
  39. SUPPORT Principal Investigators . A controlled trial to improve care for seriously ill hospitalized patients. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA. 2000;274:1591–1598
  40. Leach D. The ACGME competencies (substance or form? Accreditation Council for Graduate Medical Education). J Am Coll Surg. 2001;192:396–398
  41. The American Board of Surgery . Booklet of information. July 2002-June 2003. Philadelphia, PA: The American Board of Surgery Inc; 2002;
  42. Cox S, Pories W. Surgical resident curriculum. 3rd edition. Arlington, VA: The Association of Program Directors in Surgery; 1999;
  43. Rappaport W, Prevel C, Witzke D, et al.  Education about death and dying during surgical residency. Am J Surg. 1991;161:690–692
  44. Sloan PA, Donnelly MB, Schwartz RW, Sloan DA. Residents’ management of the symptoms associated with terminal cancer. Hospice J. 1997;12:5–15
  45. Sloan PA, Donnelly MB, Schwartz RW, Sloan PA. Cancer pain assessment and management by housestaff. Pain. 1996;67:475–481
  46. Helme RD, Gibson SJ. The epidemiology of pain in elderly people. Clin Geriatr Med. 2001;17:417–431
  47. Lillemoe KD, Cameron JL, Kaufman HS, et al.  Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg. 1993;217:447–455
  48. Brown DL, Caswell RE, Wong GY, et al.  Referral of patients with pain from pancreatic cancer for neurolytic celiac plexus block. Mayo Clin Proc. 1997;72:831–834
  49. Rothenberg ML, Moore MJ, Cripps MC, et al.  A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol. 1996;7:347–353
  50. Ferris FD, Bezjak A, Rosenthal SG. The palliative uses of radiation therapy in surgical oncology patients. Surg Oncol Clin N Am. 2001;10:185–201
  51. Auchter RM, Scholtens D, Adak S, et al.  Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen (report of ECOG study 4593. Eastern Cooperative Oncology Group). Int J Radiat Oncol Biol Phys. 2001;50:1199–1206
  52. Easson AM, Asch M, Swallow CJ. Palliative general surgical procedures. Surg Oncol Clin North Am. 2001;10:161–184
  53. Gouma DJ, van Geenen R, van Gulik T, et al.  Surgical palliative treatment in bilio-pancreatic malignancy. Ann Oncol. 1999;10S4:269–272
  54. Cubiella J, Castells A, Fondevila C, et al.  Prognostic factors in nonresectable pancreatic adenocarcinoma (a rationale to design therapeutic trials). Am J Gastroenterol. 1999;94:1271–1278
  55. Krouse RS, McCahill LE, Easson AM, Dunn GP. When the sun can set on an unoperated bowel obstruction (management of malignant bowel obstruction). J Am Coll Surg. 2002;195:117–128
  56. Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire (a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability). Palliat Med. 1995;9:207–219
  57. Byock IR, Merriman MP. Measuring quality of life for patients with terminal illness (the Missoula-VITAS quality of life index). Palliat Med. 1998;12:231–244
  58. Bruera E, Kuehn N, Miller MJ, et al.  The Edmonton Symptom Assessment System (ESAS) (a simple method for the assessment of palliative care patients). J Palliat Care. 1991;7:6–9
  59. Aaronson NK, Ahmedzai S, Bergman B, et al.  The European organization for research and treatment of cancer QLQ-C30 (a quality of life instrument for use in international clinical trials in oncology). J Natl Cancer Inst. 1993;85:365–376
  60. Kyriaki M, Eleni T, Efi P, et al.  The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care (validity and reliability in a Hellenic sample). Int J Cancer. 2001;94:135–139
  61. Portenoy RK, Thaler HT, Kornblith AB, et al.  The Memorial Symptom Assessment Scale (an instrument for the evaluation of symptom prevalence, characteristics and distress). Eur J Cancer. 1994;30A:1326–1336
  62. Chang VT, Hwang SS, Feuerman M, et al.  The memorial symptom assessment scale short form (MSAS-SF). Cancer. 2000;89:1162–1171
  63. Cella DF, Tulsky DS, Gray G, et al.  The functional assessment of cancer therapy scale (development and validation of the general measure). J Clin Oncol. 1993;11:570–579
  64. de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients (structure and application of the Rotterdam Symptom Checklist). Br J Cancer. 1990;62:1034–1038
  65. Murphy DJ, Burrows D, Santilli S, et al.  The influence of the probability of survival on patients’ preferences regarding cardiopulmonary resuscitation. N Engl J Med. 1994;330:545–549
  66. Emanuel LL, Barry MJ, Stocckle JD, et al.  Advance directives for medical care—a case for greater use. N Engl J Med. 1991;324:889–895
  67. Lipsett PA, Swoboda SM, Dickerson J, et al.  Survival and functional outcome after prolonged intensive care unit stay. Ann Surg. 2000;231:262–268
  68. Haley SM, McHorney CA, Ware JE. Evaluation of the MOS SF-36 physical functioning scale (PF-10) (I. Unidimensionality and reproducibility of the Rasch item scale). J Clin Epidemiol. 1994;47:671–684
  69. Lipsett PA, Swoboda SM, Campbell KA, et al.  Sickness Impact Profile Score versus a Modified Short-Form survey for functional outcome assessment (acceptability, reliability, and validity in critically ill patients with prolonged intensive care unit stays). J Trauma. 2000;49:737–743
  70. Fakhry SM, Kercher KW, Rutledge R. Survival, quality of life, and charges in critically ill surgical patients requiring prolonged ICU stays. J Trauma. 1996;41:999–1007
  71. Keenan SP, Busche KD, Chen LM, et al.  A retrospective review of a large cohort of patients undergoing the process of withholding or withdrawal of life support. Crit Care Med. 1997;25:1324–1331
  72. Mittelberger JA, Lo B, Martin D, Uhlmann RF. Impact of a procedure-specific do not resuscitate order form on documentation of do not resuscitate orders. Arch Intern Med. 1993;153:228–232
  73. Rapoport J, Teres D, Lemeshow S. Resource use implications of do not resuscitate orders for intensive care unit patients. Am J Respir Crit Care Med. 1996;153:185–190
  74. Jayes R, Zimmerman J, Wagner D, Knaus W. Variations in the use of do-not-resuscitate orders in the ICU (findings from a national study). Chest. 1996;110:1332–1339
  75. Nelson JE, Meier DE, Oei EJ, et al.  Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med. 2001;29:277–282
  76. Desbiens NA, Wu AW, Broste SK, et al.  Pain and satisfaction with pain control in seriously ill hospitalized adults (findings from the SUPPORT research investigations. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment). Crit Care Med. 1996;24:1953–1961
  77. Puntillo KA. Pain experiences of intensive care unit patients. Heart Lung. 1990;19:526–533
  78. Whipple JK, Lewis KS, Quebbeman EJ, et al.  Analysis of pain management in critically ill patients. Pharmacotherapy. 1995;15:592–599
  79. Uhlmann RF, Pearlman RA, Cain KC. Physicians’ and spouses’ predictions of elderly patients’ resuscitation preferences. J Gerontol. 1998;43:M115–M121
  80. Koch KA, Rodeffer HD, Wears RL. Changing patterns of terminal care management in an intensive care unit. Crit Care Med. 1994;22:233–243
  81. Curtis JR, Patrick DL, Shannon SE, et al.  The family conference as a focus to improve communication about end-of-life care in the intensive care unit (opportunities for improvement). Crit Care Med. 2001;29(2 Suppl):N26–N33
  82. Casarett DJ, Karlawish JH. Are special ethical guidelines needed for palliative care research?. J Pain Symptom Manage. 2000;20:130–139
  83. Janssens R, Gordijn B. Clinical trials in palliative care (an ethical evaluation). Patient Educat Counsel. 2000;41:55–62
  84. Kristjanson LJ, Hanson EJ, Balneaves L. Research in palliative care populations (ethical issues). J Palliat Care. 194;10:10–15
  85. Lawton J. Gaining and maintaining consent (ethical concerns raised in a study of dying patients). Qual Health Res. 2001;11:693–705
  86. McCahill LE, Krouse RS, Chu DZ, et al.  Decision making in palliative surgery. J Am Coll Surg. 2002;195:411–422
  87. McLeod RS. Issues in surgical randomized controlled trials. World J Surg. 1999;23:1210–1214
  88. de Raeve L. Ethical issues in palliative care research. Pall Med. 1994;8:298–305
  89. Clark D, Ingleton C, Seymour J. Support and supervision in palliative care research. Palliat Med. 2000;14:441–446
  90. Foley KM, Gelband H, eds. Improving palliative care for cancer, summary and recommendations. National Cancer Policy Board, Institute of Medicine and National Research Council. Washington, DC: National Academy Press; 2001
  91. Rhymes JA. Barriers to palliative care. Cancer Control 1996;3:230–223
  92. Rubenfeld GD, Randall CJ. End-of-life care in the intensive care unit (a research agenda). Crit Care Med. 2001;29:2001–2006
  93. Spitzer WO, Dobson AJ, Hall J, et al.  Measuring the quality of life of cancer patients (a concise QL-index for use by physicians). J Chronic Dis. 1981;34:585–597
  94. Weeks JC, O’Leary J, Fairclough D, et al.  A new tool for assessing health-related quality of life and utilities in clinical trials and clinical practice. Proc Am Soc Clin Oncol. 1994;13:436
  95. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients (The Functional Living Index-Cancer: development and validation). J Clin Oncol. 1984;2:472–483
  96. Baum M, Priestman T, West RR, Jones EM. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer. 1984;2(Suppl 1):223–226
  97. Padilla GV, Grant MM. Quality of life as a cancer nursing outcome variable. Adv Nurs Sci. 1985;8:45–60
  98. Gelber RD, Goldhirsch A, Cole BF. Evaluation of effectiveness (Q-TWiST. The International Breast Cancer Study Group). Cancer Treat Rev. 1993;19(Suppl A):73–84
  99. Eypasch E, Williams JI, Wood-Dauphinee S, et al.  Gastrointestinal Quality of Life Index (development, validation and application of a new instrument). Br J Surg. 1995;82:216–222
  100. Sloan JA, Loprinzi CL, Kuross SA, et al.  Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998;16:3662–3673

 No competing interests declared.

PII: S1072-7515(02)01703-9

Journal of the American College of Surgeons
Volume 196, Issue 1 , Pages 141-151 , January 2003